4,970
Views
4
CrossRef citations to date
0
Altmetric
Respiratory

Economic impact and chronic obstructive pulmonary disease outcomes of a comprehensive inhaler to nebulization therapy protocol implementation in a large multi-state healthcare system

Pages 1805-1817 | Received 07 Feb 2019, Accepted 04 Jun 2019, Published online: 01 Jul 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Igor Z Barjaktarevic & Aaron P Milstone. (2020) Nebulized Therapies in COPD: Past, Present, and the Future. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1665-1677.
Read now

Articles from other publishers (3)

Paul M. Boylan, Jordan A. Fuller, Corey M. Guidry & Stephen Neely. (2024) Estimating Tiotropium Wasted Doses After Adding Revefenacin to an Inpatient Formulary: A Single-Center Cross-Sectional Study. Hospital Pharmacy 59:3, pages 353-358.
Crossref
David Nguyen, Trent Larson, Heather Leinbach & Emily Guthrie. (2020) Systemic Steroid and Nebulized Budesonide Combination Therapy Versus Systemic Steroid Monotherapy in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in a Community Hospital: A Retrospective Cohort Study. Hospital Pharmacy 56:6, pages 786-791.
Crossref
Elizabeth Gonzalez, Jason Alan Glick, Guogen Shan & Jeffery N Talbot. (2021) Economic and workload impact of therapeutic interchange of inhaler medications and nebulizer solutions. American Journal of Health-System Pharmacy 78:1, pages 41-48.
Crossref